Myokine Secretion following an Aerobic Exercise Intervention in Individuals with Type 2 Diabetes with or without Exercise Resistance

Léa Garneau,Erin E. Mulvihill,Steven R. Smith,Lauren M. Sparks,Céline Aguer
DOI: https://doi.org/10.3390/ijms25094889
IF: 5.6
2024-05-01
International Journal of Molecular Sciences
Abstract:Type 2 diabetes (T2D) is characterized by muscle metabolic dysfunction that exercise can minimize, but some patients do not respond to an exercise intervention. Myokine secretion is intrinsically altered in patients with T2D, but the role of myokines in exercise resistance in this patient population has never been studied. We sought to determine if changes in myokine secretion were linked to the response to an exercise intervention in patients with T2D. The participants followed a 10-week aerobic exercise training intervention, and patients with T2D were grouped based on muscle mitochondrial function improvement (responders versus non-responders). We measured myokines in serum and cell-culture medium of myotubes derived from participants pre- and post-intervention and in response to an in vitro model of muscle contraction. We also quantified the expression of genes related to inflammation in the myotubes pre- and post-intervention. No significant differences were detected depending on T2D status or response to exercise in the biological markers measured, with the exception of modest differences in expression patterns for certain myokines (IL-1β, IL-8, IL-10, and IL-15). Further investigation into the molecular mechanisms involving myokines may explain exercise resistance with T2D; however, the role in metabolic adaptations to exercise in T2D requires further investigation.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper attempts to address whether myokine signaling is related to the effects of exercise intervention in patients with type 2 diabetes (T2D), particularly in those who do not respond to exercise intervention. Specifically, the researchers aim to explore: 1. Whether changes in myokine secretion are related to the response of T2D patients to exercise intervention. 2. Whether there is an exercise resistance phenomenon in T2D patients and whether this phenomenon is related to changes in myokine secretion. 3. The changes in myokine concentrations in serum and the changes in myokine secretion from primary myocytes isolated from muscle biopsy samples after exercise intervention. The study found that the levels of myokines measured in serum and culture medium did not show significant differences, but some changes were observed at the gene expression level, particularly in myokines such as IL-1β, IL-8, IL-10, and IL-15. These results suggest that myokines may play an important role in the metabolic adaptation process of T2D patients, but the specific molecular mechanisms require further research.